These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16422557)

  • 1. A work in progress.
    Bloice C; Hallinan C
    Revolution (Oakl); 2005; 6(6):14-21. PubMed ID: 16422557
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunizing the world.
    Gates B; Gates M
    Newsweek; 2000 Dec; 136(26A):72-3. PubMed ID: 11147309
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs and vaccines around the world.
    Health Aff (Millwood); 2006; 25(2):312. PubMed ID: 16522572
    [No Abstract]   [Full Text] [Related]  

  • 4. Protecting research and a case for optimism.
    Gates B
    Sci Transl Med; 2013 Dec; 5(214):214ed21. PubMed ID: 24307689
    [No Abstract]   [Full Text] [Related]  

  • 5. Fostering partnerships for vaccine development: a delicate fabric.
    Douglas RG
    Bull N Y Acad Med; 1996; 73(1):113-23. PubMed ID: 8804744
    [No Abstract]   [Full Text] [Related]  

  • 6. Global health experts explore ways to slash vaccine prices and expand access.
    Zarocostas J
    BMJ; 2011 May; 342():d3287. PubMed ID: 21613348
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccine venture boosts health hopes.
    Butler D
    Nature; 2009 Sep; 461(7262):323. PubMed ID: 19759588
    [No Abstract]   [Full Text] [Related]  

  • 8. The new relationship between physicians & industry.
    Van Way CW
    Mo Med; 2007; 104(5):375-7. PubMed ID: 18018517
    [No Abstract]   [Full Text] [Related]  

  • 9. [The Global Alliance helps children to fight diseases].
    Stenson B
    Lakartidningen; 2002 May; 99(19):2180-1. PubMed ID: 12082936
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving access to vaccines through tiered pricing.
    Berkley S
    Lancet; 2014 Jun; 383(9936):2265-7. PubMed ID: 24636625
    [No Abstract]   [Full Text] [Related]  

  • 11. Industry, governments, and nonprofits worldwide join effort to develop AIDS vaccine.
    AIDS Patient Care STDS; 1996 Oct; 10(5):310-1. PubMed ID: 11361530
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of globalization on vaccine development and availability.
    Milstien JB; Kaddar M; Kieny MP
    Health Aff (Millwood); 2006; 25(4):1061-9. PubMed ID: 16835187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine partnerships to tackle neglected diseases.
    Hughes B
    Nat Rev Drug Discov; 2008 Apr; 7(4):277-8. PubMed ID: 18396477
    [No Abstract]   [Full Text] [Related]  

  • 14. The GO License: only part of the solution.
    Batson A; Milstien JB
    Health Aff (Millwood); 2008; 27(1):140-2. PubMed ID: 18180489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Africa could learn from India's burgeoning pharma sector.
    Selvaraj S
    BMJ; 2013 Aug; 347():f4235. PubMed ID: 23913693
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress report on the National Immunization Strategy.
    Kondro W
    CMAJ; 2007 Jun; 176(13):1811-3. PubMed ID: 17576972
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug and vaccine development for infectious diseases: the value of priority review vouchers.
    Matheny J; Smith B; Courtney B; Mair M
    Clin Pharmacol Ther; 2009 Jun; 85(6):571-2. PubMed ID: 19451907
    [No Abstract]   [Full Text] [Related]  

  • 18. A real shot.
    Diamond B
    Nat Med; 2005 Apr; 11(4 Suppl):S3-4. PubMed ID: 15812487
    [No Abstract]   [Full Text] [Related]  

  • 19. Preventing vaccine-preventable diseases in low-resource communities.
    Rodewald LE; Markowitz LE
    Arch Pediatr Adolesc Med; 2009 May; 163(5):487-8. PubMed ID: 19414699
    [No Abstract]   [Full Text] [Related]  

  • 20. Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.
    Kesselheim AS
    Clin Pharmacol Ther; 2009 Jun; 85(6):573-5. PubMed ID: 19451908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.